Concepedia

Anna McLaughlin

AM

12

Publications

879

Citations

11

H-Index

2001

Active since

Affiliations

King's College London(Current)

South London and Maudsley NHS Foundation Trust

National Institute for Health Research

Cardiff University

Warneford Hospital

Anna McLaughlin is an author at King's College London specializing in medicine, neuroinflammation, and cell death.

ORCID

Top concepts

Publications per year

2001–2023

12

Publications

12

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice

Renzo Mancuso, Gemma Fryatt, Madeleine Cleal et al. · Brain · 2019 · 224 citations · Full text

, , +17

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

Maria Antonietta Nettis, Giulia Lombardo, Caitlin Hastings et al. · Neuropsychopharmacology · 2021 · 220 citations · Full text

Childhood trauma, HPA axis activity and antidepressant response in patients with depression

Naghmeh Nikkheslat, Anna McLaughlin, Caitlin Hastings et al. · Brain Behavior and Immunity · 2019 · 119 citations · Full text

Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study

Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner et al. · Translational Psychiatry · 2020 · 111 citations · Full text

Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study

Gemma Modinos, Anna McLaughlin, Alice Egerton et al. · Translational Psychiatry · 2017 · 37 citations · Full text

Rows per page

1–5 of 12